Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lyrica (Pregabalin) – the Drug Treatment For Relieve Neuropathic Pain

Drug (Brand/Generic)

Lyrica / pregabalin

Company/Licensee

Pfizer

Therapy Class

Antiepileptic

Product Description

GABA analogue

Current Indication

Treatment of neuropathic pain, adjunctive therapy in epilepsy and treatment of generalised anxiety disorder

Market Sector

CNS, pain control

Development Status

Approved for neuropathic pain in Europe and the US and additionally for partial seizures in Europe and the US
Expand

Go Top